Evaluation of lenalidomide (Revlimid [R]) to treat subjects with Cutaneous Lupus Erythematosus (CLE)

Source :: Journal of Drugs in Dermatology. April, 2009, Vol. 8 Issue 4, p424, 1 p.
Publication Year :: 2009
Abstract: Sponsored by University of Pennsylvania; Celgene Corporation. This study is being conducted to evaluate the safety and effectiveness of lenalidomide (Revlimid[R]) in subjects with Cutaneous Lupus Erythematosus (CLE).The study drug [...]

Subjects :: Celgene Corp. -- Product development
Lupus erythematosus -- Drug therapy
Pharmaceutical industry -- Product development
Health
Pharmaceuticals and cosmetics industries
Revlimid (Medication) -- Complications and side effects
Revlimid (Medication) -- Dosage and administration

Tools